BMS1P10

Across TCGA pan-cancer cohorts, BMS1P10 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of BMS1P10’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where BMS1P10 RNA is repressed in tumor relative to normal tissue. In most cancer types BMS1P10 is over-expressed in tumor, although a few such as HNSC and KICH show the opposite, repressed pattern.

HNSC, KICH, and LUAD are the cancer types where BMS1P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BMS1P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	−0.650	<.001	8	view →
KICH	All	All	−0.679	<.001	7	view →
LUAD	All	All	+0.476	<.001	7	view →
BRCA	All	All	−0.440	<.001	6	view →
LIHC	Male	All	+0.593	<.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

BMS1P10–HNSC

Open the HNSC breakdown →